Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy b
3 days ago
- #dopaminergic imaging
- #MIBG scintigraphy
- #Lewy bodies
- Delphi consensus guidelines developed for using striatal dopaminergic imaging and cardiac MIBG scintigraphy in diagnosing dementia and mild cognitive impairment with Lewy bodies.
- A panel of 37 international experts participated, agreeing on statements with >80% consensus.
- 51% of statements were accepted in both Round 1 (36/70) and Round 2 (19/37).
- Guidelines outline clinical situations where these biomarkers are useful, considering comorbidities and medications.
- Conflicts of interest noted among some authors, including funding and honoraria from GE Healthcare and other entities.